2oyu
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:2oyu.gif|left|200px]] | [[Image:2oyu.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_2oyu", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | + | or leave the SCENE parameter empty for the default display. | |
| - | | | + | --> |
| - | | | + | {{STRUCTURE_2oyu| PDB=2oyu | SCENE= }} |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''Indomethacin-(S)-alpha-ethyl-ethanolamide bound to Cyclooxygenase-1''' | '''Indomethacin-(S)-alpha-ethyl-ethanolamide bound to Cyclooxygenase-1''' | ||
| Line 28: | Line 25: | ||
[[Category: Garavito, R M.]] | [[Category: Garavito, R M.]] | ||
[[Category: Harman, C A.]] | [[Category: Harman, C A.]] | ||
| - | [[Category: | + | [[Category: Cox]] |
| - | [[Category: | + | [[Category: Heme]] |
| - | [[Category: | + | [[Category: Indomethacin]] |
| - | [[Category: | + | [[Category: Nsaid]] |
| - | [[Category: | + | [[Category: Oxidoreductase]] |
| - | [[Category: | + | [[Category: Pgh]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 11:57:27 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 08:57, 4 May 2008
Indomethacin-(S)-alpha-ethyl-ethanolamide bound to Cyclooxygenase-1
Overview
The modification of the nonselective nonsteroidal anti-inflammatory drug, indomethacin, by amidation presents a promising strategy for designing novel cyclooxygenase (COX)-2-selective inhibitors. A series of alpha-substituted indomethacin ethanolamides, which exist as R/S-enantiomeric pairs, provides a means to study the impact of stereochemistry on COX inhibition. Comparative studies revealed that the R- and S-enantiomers of the alpha-substituted analogs inhibit COX-2 with almost equal efficacy, whereas COX-1 is selectively inhibited by the S-enantiomers. Mutagenesis studies have not been able to identify residues that manifest the enantioselectivity in COX-1. In an effort to understand the structural impact of chirality on COX-1 selectivity, the crystal structures of ovine COX-1 in complexes with an enantiomeric pair of these indomethacin ethanolamides were determined at resolutions between 2.75 and 2.85 A. These structures reveal unique, enantiomer-selective interactions within the COX-1 side pocket region that stabilize drug binding and account for the chiral selectivity observed with the (S)-alpha-substituted indomethacin ethanolamides. Kinetic analysis of binding demonstrates that both inhibitors bind quickly utilizing a two-step mechanism. However, the second binding step is readily reversible for the R-enantiomer, whereas for the S-enantiomer, it is not. These studies establish for the first time the structural and kinetic basis of high affinity binding of a neutral inhibitor to COX-1 and demonstrate that the side pocket of COX-1, previously thought to be sterically inaccessible, can serve as a binding pocket for inhibitor association.
About this Structure
2OYU is a Single protein structure of sequence from Ovis aries. Full crystallographic information is available from OCA.
Reference
Structural basis of enantioselective inhibition of cyclooxygenase-1 by S-alpha-substituted indomethacin ethanolamides., Harman CA, Turman MV, Kozak KR, Marnett LJ, Smith WL, Garavito RM, J Biol Chem. 2007 Sep 21;282(38):28096-105. Epub 2007 Jul 26. PMID:17656360 Page seeded by OCA on Sun May 4 11:57:27 2008
